Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • FDA Grants Novavax’s COVID-19 Vaccine Emergency Use Authorization For Adolescents Ages 12 To 17

    CNN (8/19, Howard) reported the FDA “authorized Novavax’s COVID-19 vaccine on Friday for emergency use in adolescents.” Novavax’s protein-based “vaccine was authorized for adults in July,” and with this “latest emergency use authorization, it also will be...
    Full Article
  • Democratic Republic Of Congo Health Authorities Investigating Suspected Ebola Case, WHO Says

    Reuters (8/20, Ross) reported, “Health authorities in the Democratic Republic of Congo are investigating a suspected case of Ebola in the country’s east, the World Health Organization said on Saturday.” Reuters added “a 46-year-old woman died” last week “...
    Full Article
  • Several Countries Seeing Cases Of Vaccine-Derived Polio

    The AP (8/21, Cheng) reports, “For years, global health officials have used billions of drops of an oral vaccine in a remarkably effective campaign aimed at wiping out polio in its last remaining strongholds – typically, poor, politically unstable corners...
    Full Article
  • FDA Asks Pfizer To Test Additional Course Of Paxlovid Among People Who Experience COVID-19 Rebound

    Reuters (8/19, Leo) reported the FDA “has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday.” The company “must produce th...
    Full Article
  • WHO Recommends Use Of Two Monoclonal Antibody Treatments For Ebola Virus Disease

    Healio (8/19, Gallagher) reported, “WHO has recommended two monoclonal antibody treatments for Ebola virus disease.” These “treatments, mAb114 [ansuvimab] and REGN-EB3 [atoltivimab/maftivimab/odesivimab], were effective in a groundbreaking randomized cont...
    Full Article
  • White House Officials Announce New Steps To Expand Monkeypox Vaccine Access

    The Washington Post (8/18, A1, Diamond, Nirappil) reports that on Thursday, White House officials “touted steps to expand access to monkeypox vaccines.” Among the steps, the officials announced “an additional 1.8 million doses would be available for order...
    Full Article
  • New COVID-19 Cases Decline 24% Globally, WHO Says

    The AP (8/18, D'Innocenzio, Chapman) reports, “New coronavirus cases reported globally dropped nearly a quarter in the last week while deaths fell 6% but were still higher in parts of Asia, according to a report Thursday on the pandemic by the World Healt...
    Full Article
  • Polio Eradication Efforts Face Several Setbacks This Year

    The New York Times (8/18, Mandavilli) reports that “at the beginning of this year, there was a thrum of excitement among global health experts: Eradication of polio,” but “there were several ominous setbacks,” as cases were reported in several countries a...
    Full Article
  • Naegleria Fowleri Infection Believed To Be Cause Of Child Fatality In Nebraska

    USA Today (8/18, Grantham-Philips) reports, “A Nebraska child has died from a suspected infection of Naegleria fowleri, or brain-eating amoeba, local health officials said.” According to the Nebraska Department of Health and Human Services, “the child was...
    Full Article
  • US To Offer Extra 50,000 Monkeypox Vaccine Doses For Upcoming Gay Pride Events

    The AP (8/18, Stobbe) reports, “The U.S. is setting aside an extra 50,000 doses of monkeypox vaccine for places with upcoming gay pride events, health officials said Thursday.” The number of doses allocated for “each place will be based on factors like th...
    Full Article
  • Bavarian Nordic, US Manufacturer Reach Agreement To Expedite Delivery Of Monkeypox Vaccine Doses

    The Hill (8/18, Weixel) reports an agreement between Bavarian Nordic and Michigan-based Grand River Aseptic Manufacturing (GRAM) “would move the final packaging steps to the U.S. in an effort to expedite the delivery of millions of doses” of the Jynneos m...
    Full Article
  • White House COVID-19 Coordinator Says Updated Vaccines Expected To Be Available In “A Few Short Weeks” For People Over Age 12

    The Hill (8/18, Sullivan) reports that on Wednesday, White House COVID-19 Response Coordinator Dr. Ashish Jha “said...that updated COVID-19 vaccines are expected to be available in ‘a few short weeks’ for everyone over the age of 12.” These “new vaccines...
    Full Article
  • Laboratory Supply Shortages: Turning Crisis to Opportunity

    Abstract Not Available
    Full Article
  • Historical Contributions to Blood Banking and Transfusion Medicine 1922 vs. 2022 and Beyond

    Abstract Not Available
    Full Article
  • Lymphocyte Subset Panels (AKA T4T8 Assays)

    Abstract Not Available
    Full Article
  • Biden Administration Planning To Stop Buying COVID-19 Products As Early As This Fall, Official Says

    CNN (8/16, Goodman) reports, “The Biden administration has been planning for how to get past the crisis phase of the COVID-19 pandemic and will stop buying vaccines, treatments and tests as early as this fall, White House COVID-19 Response Coordinator Dr....
    Full Article
  • Scientists Explore Efficacy Of BCG Tuberculosis Vaccine To Provide Universal Protection Against COVID-19, Infectious Diseases

    The New York Times (8/16, Rabin) reports, “In the early days of the COVID-19 pandemic...several scientists launched trials to see whether a tuberculosis vaccine developed in the early 1900s might protect people by bolstering the immune system.” And now, “...
    Full Article
  • Dupilumab May Benefit Patients Hospitalized With Moderate-To-Severe COVID-19, Trial Suggests

    HealthDay (8/16) reports that “early research suggests that dupilumab, a monoclonal antibody used to treat asthma and eczema, may benefit patients hospitalized with moderate-to-severe COVID-19, according to” a “phase 2a randomized, double-blind, placebo-c...
    Full Article
  • Triple Therapy With Ribavirin, Sofosbuvir, And Daclatasvir Increases SVR Achievement In Patients With HCV Complicated By Cirrhosis, Study Finds

    Infectious Disease Advisor (8/16, Paridon) reports “triple therapy with ribavirin plus sofosbuvir and daclatasvir increases the rate [of] sustained virologic response (SVR) achievement in patients with hepatitis C virus (HCV) infection complicated by cirr...
    Full Article
  • Polio May Have Been Circulating Widely For A Year, Present In New York As Early As April, CDC Says

    The New York Times (8/16, Anthes) reports, “Polio may have been circulating widely for a year, and was present in New York’s wastewater as early as April, according to a new report from the Centers for Disease Control and Prevention.” The Times adds, “A w...
    Full Article
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id